axitinib Articles
Robust growth forecast for renal cell carcinoma market
11 December 2011
Pfizer’s axitinib favored by FDA panel
9 December 2011
Pfizer commences rolling FDA submission for lung cancer drug crizotinib; denies German VAT evasion
17 January 2011
Bristol-Myers Squibb and Pfizer drop development of apixaban in acute coronary syndrome, but good news for Pfizer with axitinib
22 November 2010
Showing 1-7 of 7 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
